Welcome to the Takeda Oncology Newsroom. This section is dedicated to providing the most up-to-date information about our company, our people and our science.
For other Takeda news releases, please visit the Takeda.com Newsroom.
Takeda to Hold Oncology Focused Investor Call on June 8
Marketing Approval Received in Japan for NINLARO® as a Maintenance Therapy after First-Line Treatment for Multiple Myeloma without Prior Stem Cell Transplantation
Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML